Literature DB >> 28915581

Up-regulation of LINC00161 correlates with tumor migration and invasion and poor prognosis of patients with hepatocellular carcinoma.

Li-Chao Xu1, Quan-Ning Chen2, Xi-Qiang Liu3, Xiao-Ming Wang3, Qi-Meng Chang4, Qi Pan5, Lu Wang5, Yi-Lin Wang5.   

Abstract

Accumulating evidence suggested that long non-coding RNAs (lncRNAs) play essential roles in various biological processes, including tumorigenesis. Aberrant expression of LINC00161 has been reported in some cancer types, however, the association of LINC00161 and hepatocellular carcinoma (HCC) has not been evaluated. Here, we measured the expression of LINC00161 in HCC tissues and corresponding normal liver tissues using real-time PCR. The result showed that the expression level of LINC00161 was significantly higher in HCC tissues. Further analysis indicated that HCC patients with higher LINC00161 expression have shorter survival. Multivariate Cox regression analysis showed that LINC00161 expression was an independent prognostic factor for the overall survival. Furthermore, our result indicated that knock-down of LINC00161 can significantly inhibit liver cancer cell migration and invasion. The present work indicated that LINC00161 might serve as an oncogenic gene and play a pivotal role in promoting tumor migration and invasion in HCC. Our work implicates the promising effect of LINC00161 on the prognosis of HCC.

Entities:  

Keywords:  LINC00161; hepatocellular carcinoma; invasion; prognosis; tumor cell migration

Year:  2017        PMID: 28915581      PMCID: PMC5593552          DOI: 10.18632/oncotarget.17040

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


INTRODUCTION

Liver cancer has become the fifth most frequently diagnosed cancer and third leading cause of cancer death worldwide [1, 2]. Hepatocellular carcinoma (HCC) is the most common histological subtype of liver cancers, and accounts for 75% of all cases. The risk factors of HCC patients are associated with geographic region and ethnic background [3]. Until now, the most effective therapy method for HCC is still complete resection. It is still difficult for the early diagnosis of HCC. So, exploring the pathogenesis and biological features of HCC is crucial for early detection and treatment. Long non-coding RNAs (lncRNAs) are a class of transcripts with the size longer than 200 nucleotides. Recent works have shown that lncRNAs play important roles in various biological processes by modulating gene expression through chromatin organization [4, 5]. Many cancer-associated lncRNAs have been reported to be novel independent biomarkers for cancer diagnosis and prognosis in different types of cancers, such as breast cancer [6, 7], oesophageal squamous cell carcinoma [8], colorectal cancer [9], lung cancer [10] and ovarian cancer [11]. For example, lncRNA-p21 has been documented to be involved in cell apoptosis and regulation of Warburg effect [12]. Moreover, some lncRNAs have been identified to regulate chemoresistance in many cancers, such as MEG3 [13]. Previous works have identified several lncRNAs to be associated with the progression of HCC, such as FTX and PCAT-1 [14-16]. In the present work, we examine the influence of LINC00161 expression on HCC tumorigenesis. LINC00161 is a novel lncRNA, which has been reported to play important role in osteosarcoma [17]. Here, we examined the expression difference of LINC00161 between HCC tissues and corresponding normal liver tissues, and evaluated the clinical significance of LINC00161 in HCC patients. Moreover, we examined the effects of LINC00161 on HCC cells migration and invasion, which suggests the potential effects of LINC00161 on HCC prognosis.

RESULTS

The expression of LINC00161 in HCC tissues and cell lines

Here, we examined the expression level of LINC00161 in 104 pairs of HCC tissues and adjacent liver tissues using quantitative RT-PCR. The result demonstrated that LINC00161 expression level was significantly up-regulated in HCC tissues compared with matched normal liver tissues (P-value < 0.001, Figure 1A). Next, we analyzed the expression level of LINC00161 in different cell lines, and the result showed that LINC00161 expressions in HCC cell lines (HepG2, Hep3B, Huh7 and SMMC7721) were significantly higher compared with normal liver cell line LO2 (Figure 1B). This result suggests that LINC00161 might play an oncogenic role in liver cancer tumorigenesis.
Figure 1

The relative expression levels of LINC00161 in HCC tissues and cell lines

(A) The relative expression of LINC00161 in HCC tissues and adjacent non-tumor liver tissues. The bars represent the means of the relative expression of LINC00161. (B) the relative expression of LINC00161 in HCC cell lines.

The relative expression levels of LINC00161 in HCC tissues and cell lines

(A) The relative expression of LINC00161 in HCC tissues and adjacent non-tumor liver tissues. The bars represent the means of the relative expression of LINC00161. (B) the relative expression of LINC00161 in HCC cell lines.

Clinical significance of LINC00161 expression in HCC

Next, we evaluated the association between LINC00161 expression and clinicopathological characteristics. The enrolled 104 HCC patients were divided into two equal groups according to the median value of LINC00161 expression level (high-expression group and low-expression group). Then, we examined the correlation between LINC00161 expression level and clinicopathological factors of HCC patients. The result showed that higher expression value of LINC00161 was tightly associated with tumor grade (P-value = 0.0012, Table 1), and no significant differences of other characteristics were found in HCC patients. Kaplan-Meier survival analysis revealed that HCC patients with higher LINC00161 expression level correlated with shorter overall survival (P-value = 0.001, Figure 2). Univariate proportional hazard model indicated that the tumor grade and LINC00161 expression level was prognostic predictors. Those characteristics of HCC patients which are associated with overall survival in the univariate Cox analysis were further evaluated in a multivariate Cox model. The result showed that LINC00161 expression level (P-value = 0.001, Table 2) was an independent prognostic factor for predicting the 5-year overall survival of HCC patients.
Table 1

Clinicopathological associations of LINC00161 expression in HCC patients

LINC00161 expression
VariableHigh (n = 52)Low (n = 52)P-value
Ages (years)0.88
  < 502023
  ≥ 503229
Gender0.96
  Male3533
  Female1719
Tumor size0.22
  < 5 cm3138
  ≥ 5 cm2114
Serum AFP (ng/l)0.74
  < 4001917
  ≥ 4003335
Lymph node metastasis0.24
  No2124
  Yes3128
Alcohol abuse0.99
  No2625
  Yes2627
Tumor grade0.0012
  G11326
  G21816
  G32110
Figure 2

Kaplan-Meier survival curves of patients with HCC based on LINC00161 expression status

Patients with higher expression group have significantly poorer prognosis than those in lower expression group.

Table 2

Univariate and multivariate analyses of prognostic factors in HCC patients

VariablesUnivariate analysisMultivariate analysis
HR95% CIP-valueHR95% CIP-value
age (Years)1.440.96–1.650.281.410.72–1.520.36
gender1.430.92–2.140.331.340.91–2.110.48
Alcohol abuse1.681.01–2.110.411.581.02–1.980.55
Lymph node metastasis1.580.89–1.880.911.440.77–1.670.66
tumor size1.481.06–1.720.081.360.91–1.680.18
tumor grade2.061.05–3.460.00151.571.21–3.330.092
LINC001611.440.83–1.89< 0.0011.370.85–1.860.001

Kaplan-Meier survival curves of patients with HCC based on LINC00161 expression status

Patients with higher expression group have significantly poorer prognosis than those in lower expression group.

In vitro effect of LINC00161 on HCC cell migration and invasion

To investigate whether LINC00161 can influence HCC cell migration and invasion, we performed in vitro Transwell assay in Huh7 cell line. The result showed that knock-down of LINC00161 significantly inhibit HCC cell migration and invasion (Figure 3), suggesting that LINC00161 might play an important role in the tumorigenesis of HCC.
Figure 3

Effects of LINC00161 on migration and invasion of Huh7 cell line

(A) Transwell assay of Huh7 cells and representative fields of invasive cells. (B) Average number of invasive cells per field from three independent experiments.

Effects of LINC00161 on migration and invasion of Huh7 cell line

(A) Transwell assay of Huh7 cells and representative fields of invasive cells. (B) Average number of invasive cells per field from three independent experiments.

DISCUSSION

HCC is one of the most common malignancy tumors with lower survival rate. Prognostic factor detection in HCC is necessary to predict the overall survival rate and select optimal therapeutic strategy. Although many efforts have been devoted to detect potential markers in HCC [18-21], the underlying molecular mechanism is still limited. Increasing evidence has suggested that lncRNAs are widely existed in mammalian genomes and play crucial role in cell biology [22]. Until now, lncRNAs has been implemented in diverse pathological processes in cancers. Dysregulation of LINC00161 has been documented to play an important function in osteosarcoma [17]. Increasing LINC00161 can accelerate cisplatin-induced apoptosis and reduce chemoresistance. Furthermore, LINC00161 can sponge endogenous miR-645 and inhibit its expression leading to the induced expression of IFIT2. However, no study has been performed on the association between LINC00161 and HCC. In the present work, we explored the relationship between LINC00161 expression and the clinicopathogical features of HCC patients for the first time. We found that LINC00161 was significantly over-expressed in HCC tissues and cell lines compared with adjacent normal liver tissues and LO2 cell line, respectively. Multivariate survival analysis showed that LINC00161 could be used as a potential prognostic biomarker for HCC. Further functional analysis indicated that know-down of LINC00161 could significantly inhibit cell migration and invasion, which indicates that LINC00161 might function as an oncogenic gene in HCC. In summary, our work showed that LINC00161 expression was up-regulated in HCC and is significantly associated with cancer cell migration and invasion. Our findings implicated for the first time that LINC00161 expression was an independent prognostic factor and molecular therapeutic target in HCC.

MATERIALS AND METHODS

Patients and tissue samples

Liver tumor tissues and paired normal adjacent tissues were obtained from patients with a diagnosis of HCC who underwent surgery at the Yi Ji-shan Hospital (Anhui Province, China) between April 2008 and Nov 2014. Informed written consents were obtained from all enrolled HCC patients, and all patients had complete 5-year follow-up. These HCC patients had never received any radiotherapy before surgery excision. All liver tissues were immediately frozen in liquid nitrogen after surgery. This study was approved by the Ethics Committee of Shanghai Cancer Center, Fudan University.

RNA extraction and RT-PCR

The total RNA from tissue samples and cells were isolated using the TRIzol solution (Invitrogen, USA) according to the manufacturer's protocol. Quantitative RT-PCR was performed using BioRad Chromo4 real-time PCR system. GAPDH was used as an internal control, and the expression level of LINC00161 was measured using the following primer sequences: F:5-ACTTGAGTGAGGTGGGTTTC-3 and R:5-TTGGTGTTCCTTGGCTTGTA-3. Relative quantification of LINC00161 was calculated by using the 2−ΔΔCT method.

Cell culture

Four human HCC cell lines (HepG2, Hep3B, Huh7 and SMMC7721) and normal human liver cells (LO2) were purchased from Shanghai Institutes for Biological Sciences, China. The cells were cultured in RPMI-1640 medium (Gibco, USA) supplemented with 10% fetal bovine serum (FBS), 100 μ/ml penicillin and 100 mg/ml streptomycin. All these cells were grown at 37°C in a humidified atmosphere containing 5% CO2.

LINC00161 knockdown by lentiviruses

To generate lentiviruses expressing LINC00161 shRNA and control shRNAs, Huh7 cells were transfected with 5μg of shRNAs. After transfection, Huh7 cells were cultured with DMEM medium containing 10% FBS for 36 hours. The medium containing lentivirus particles was centrifuged at 10000×g for 2 min and used for infection.

Cell migration and invasion assays

The cell invasion assay was performed using a 24-well Transwell chamber (Costar, USA) without Matrigel coating. For migration assay, a total of 2 × 105 transfected cells were added to the upper chamber of Transwell assay inserts. Then, the inserts were added to the bottom chamber wells filled with conditioned medium. After the incubation for 24 hours and stained with hematoxylin for 10 minutes, we calculated the number of cell in five random fields for each chamber. For invasion assay, transfected cells were plated in the top chamber with a Matrigel-coated membrane in the bottom chambers.

Statistical analysis

Statistical significance between groups was measured using student's t-test. Kaplan-Meier method and log-rank test were used to measure the overall survival rate. The Cox proportional hazards model was applied for the multivariate analysis. All statistical analyses were carried out using SPSS version 16.0, and results were considered statistically significant at P-value < 0.05.
  22 in total

1.  Hepatitis B virus infection in hepatocellular carcinoma tissues upregulates expression of DNA methyltransferases.

Authors:  Haiping Li; Fengmei Yang; Bo Gao; Zongtao Yu; Xiaobo Liu; Fei Xie; Jicai Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  International trends in liver cancer incidence rates.

Authors:  Melissa M Center; Ahmedin Jemal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-15       Impact factor: 4.254

3.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals.

Authors:  Mitchell Guttman; Ido Amit; Manuel Garber; Courtney French; Michael F Lin; David Feldser; Maite Huarte; Or Zuk; Bryce W Carey; John P Cassady; Moran N Cabili; Rudolf Jaenisch; Tarjei S Mikkelsen; Tyler Jacks; Nir Hacohen; Bradley E Bernstein; Manolis Kellis; Aviv Regev; John L Rinn; Eric S Lander
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

4.  Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score.

Authors:  Satoshi Kitai; Masatoshi Kudo; Yasunori Minami; Seiji Haji; Yukio Osaki; Hiroko Oka; Toshihito Seki; Hiroshi Kasugai; Yo Sasaki; Takashi Matsunaga
Journal:  Oncology       Date:  2008-12-17       Impact factor: 2.935

5.  Upregulation of long non coding RNA PCAT-1 contributes to cell proliferation, migration and apoptosis in hepatocellular carcinoma.

Authors:  Jifeng Wen; Jun Xu; Qifeng Sun; Chengliang Xing; Wenzhe Yin
Journal:  Mol Med Rep       Date:  2016-03-30       Impact factor: 2.952

Review 6.  Long non-coding RNAs and complex human diseases.

Authors:  Jing Li; Zhenyu Xuan; Changning Liu
Journal:  Int J Mol Sci       Date:  2013-09-12       Impact factor: 5.923

7.  Models of hepatocellular carcinoma and biomarker strategy.

Authors:  Cedo M Bagi; Catharine J Andresen
Journal:  Cancers (Basel)       Date:  2010-07-07       Impact factor: 6.639

8.  A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.

Authors:  Ye Hu; Hao-Yan Chen; Chen-Yang Yu; Jie Xu; Ji-Lin Wang; Jin Qian; Xi Zhang; Jing-Yuan Fang
Journal:  Oncotarget       Date:  2014-04-30

9.  LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma.

Authors:  Jiagen Li; Zhaoli Chen; Liqing Tian; Chengcheng Zhou; Max Yifan He; Yibo Gao; Suya Wang; Fang Zhou; Susheng Shi; Xiaoli Feng; Nan Sun; Ziyuan Liu; Geir Skogerboe; Jingsi Dong; Ran Yao; Yuda Zhao; Jian Sun; Baihua Zhang; Yue Yu; Xuejiao Shi; Mei Luo; Kang Shao; Ning Li; Bin Qiu; Fengwei Tan; Runsheng Chen; Jie He
Journal:  Gut       Date:  2014-02-12       Impact factor: 23.059

10.  Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.

Authors:  Meng Zhou; Yanying Sun; Yifan Sun; Wanying Xu; Zhaoyue Zhang; Hengqiang Zhao; Zhaohua Zhong; Jie Sun
Journal:  Oncotarget       Date:  2016-05-31
View more
  7 in total

1.  Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma.

Authors:  Li-Na You; Qin-Wen Tai; Lin Xu; Yi Hao; Wen-Jia Guo; Qiao Zhang; Qing Tong; Heng Zhang; Wu-Kui Huang
Journal:  Cancer Gene Ther       Date:  2021-01-07       Impact factor: 5.987

Review 2.  Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells.

Authors:  Xiaoqi Huo; Shuanglin Han; Guang Wu; Olivier Latchoumanin; Gang Zhou; Lionel Hebbard; Jacob George; Liang Qiao
Journal:  Mol Cancer       Date:  2017-10-23       Impact factor: 27.401

3.  Long non‑coding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRT‑PCR and meta‑analysis of 393 cases.

Authors:  Yu Zhang; Jia-Cheng Huang; Kai-Teng Cai; Xi-Bing Yu; You-Rong Chen; Wen-Ya Pan; Ze-Liang He; Jun Lv; Zhen-Bo Feng; Gang Chen
Journal:  Int J Oncol       Date:  2017-10-16       Impact factor: 5.650

4.  The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program.

Authors:  Abhijit Parolia; Erik Venalainen; Hui Xue; Rebecca Mather; Dong Lin; Rebecca Wu; Perla Pucci; Jason Rogalski; Joseph R Evans; Felix Feng; Colin C Collins; Yuzhuo Wang; Francesco Crea
Journal:  Mol Oncol       Date:  2019-03-05       Impact factor: 6.603

Review 5.  Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma.

Authors:  Caecilia H C Sukowati; Loraine Kay D Cabral; Claudio Tiribelli; Devis Pascut
Journal:  Biomedicines       Date:  2021-01-19

Review 6.  Regulatory Roles of Noncoding RNAs in the Progression of Gastrointestinal Cancers and Health Disparities.

Authors:  Aditi Kulkarni; Sharan Gayathrinathan; Soumya Nair; Anamika Basu; Taslim A Al-Hilal; Sourav Roy
Journal:  Cells       Date:  2022-08-07       Impact factor: 7.666

7.  Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma.

Authors:  Li Sun; Yingying Su; Xiangxiang Liu; Mu Xu; Xiaoxiang Chen; Yefei Zhu; Zhirui Guo; Tingting Bai; Lin Dong; Chenchen Wei; Xiaoxiao Cai; Bangshun He; Yuqin Pan; Huiling Sun; Shukui Wang
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.